Gary Phillips - Jun 4, 2024 Form 4 Insider Report for Aldeyra Therapeutics, Inc. (ALDX)

Role
Director
Signature
/s/ Gary Phillips
Stock symbol
ALDX
Transactions as of
Jun 4, 2024
Transactions value $
$0
Form type
4
Date filed
6/6/2024, 04:06 PM
Previous filing
Sep 11, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALDX Stock Option (Right to Buy) Award $0 +40.3K $0.00 40.3K Jun 4, 2024 Common Stock 40.3K $4.09 Direct F1
transaction ALDX Stock Option (Right to Buy) Award $0 +3.47K $0.00 3.47K Jun 4, 2024 Common Stock 3.47K $4.09 Direct F2
transaction ALDX Stock Option (Right to Buy) Award $0 +2.6K $0.00 2.6K Jun 4, 2024 Common Stock 2.6K $4.09 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
F2 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Compensation Committee of the Board of Directors of the Issuer through the applicable vesting date.
F3 Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Audit Committee of the Board of Directors of the Issuer through the applicable vesting date.